HEALTH OF WOMAN. 2016.2(108):90–94; doi 10.15574/HW.2016.108.90 
 

Диагностические детерминанты функционального состояния фетоплацентарного комплекса у беременных с ожирением и метаболическим синдромом 
 

Дындарь Е. А., Никонюк Т. Р.

Национальный медицинский университет им. А.А. Богомольца, г. Киев 
 

Проведено обследование 238 беременных с целью прогнозирования перинатальных осложнений у женщин с ожирением и метаболическим синдромом путем изучения факторов ангиогенеза и состояния фетоплацентарного комплекса. 
 

Ключевые слова: беременность, ожирение, метаболический синдром, ангиогенез. 
 

Литература:

1. Kuzin AI. 2011. Metabolic's cousins a syndrome: clinical and популяционные aspects . JU.A.Lengin.-Cheljabinsk: Publishing house «Joint-Stock Company» the Chelyabinsk interdistrict printing house»:120.

2. Zadionchenko VS. 2009. A metabolic syndrome: therapeutic possibilities. Consillium Medicum 7;9:725-33.

3. Lipatov IS, Melnikov VА, Tezikov JUV. 2008. Estimation of severity level of placentary insufficiency at pregnant women. Russian bulletin of the obstetric-gynecologist: 8;5:38-43.

4. Filippov OS, Kazantsev AA. 2003. Forecasting the importance of various methods of diagnostics fetoplacental insufficiency. Reproduction Problems 3:44-49.

5. Milovanov AP. 2005. Pathologe of system mother-placenta-fetus: 2005:230.

6. Tischer E, Mitchell R, Hartman T. 2011. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. The Journal of Biological Chemistry 266;18:11947–54.

7. Muller Y.A; Li B; Christinger H.W., 2012. Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site. Proceedings of the National Academy of Sciences of the United States of America 94:14:7192–7. http://dx.doi.org/10.1073/pnas.94.14.7192

8. Andraweera PH, Dekker GA, Roberts CT. 2012. The vascular endothelial growth factor family in adverse pregnancy outcomes. Human Reproduction Update 18:4:436–457. http://dx.doi.org/10.1093/humupd/dms011; PMid:22495259

9. Ferrara N, Gerber HP. 2012. The role of vascular endothelial growth factor in angiogenesis. Acta Haematol. 106:4:148–56. http://dx.doi.org/10.1159/000046610

10. Eremina V, Quaggin SE. 2014. The role of VEGF-A in glomerular development and function. Curr. Opin. Nephrol. Hypertens. 13:1:9–15. http://dx.doi.org/10.1097/00041552-200401000-00002

11. Ribatti D. 2012. The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review. Br. J. Haematol. 128:3:303–9. http://dx.doi.org/10.1111/j.1365-2141.2004.05291.x; PMid:15667531

12. Tong JP, Yao YF. 2014. Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions. Clin. Biochem. 39:3:267–74. http://dx.doi.org/10.1016/j.clinbiochem.2005.11.013; PMid:16409998

13. Matsumoto T, Mugishima H. 2011. Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis. J. Atheroscler. Thromb. 13:3:130–5. http://dx.doi.org/10.5551/jat.13.130